back to top
HomeMarketMO Earnings: Highlights of Altria’s Q2 2024 report | AlphaStreet

MO Earnings: Highlights of Altria’s Q2 2024 report | AlphaStreet

-

Tobacco big Altria Group, Inc. (NYSE: MO) on Wednesday introduced monetary outcomes for the second quarter, reporting a lower in income and flat earnings, on an adjusted foundation.

Web revenues decreased 4.6% year-over-year to $6.21 billion within the June quarter. The decline was primarily pushed by decrease revenues within the smokeable merchandise section, partially offset by larger revenues within the oral tobacco merchandise section.

Second-quarter earnings, excluding one-off itmes, remained unchanged year-over-year at $1.31 per share. On a reported foundation, web revenue rose sharply to $3.8 billion or $2.21 per share from $2.12 billion or $1.19 per share within the prior-year quarter.

“Altria’s momentum continues to build as we pursue our Vision to responsibly lead the transition of adult smokers to a smoke-free future,” stated Billy Gifford, Altria’s CEO.

Prior Efficiency

LEAVE A REPLY

Please enter your comment!
Please enter your name here

CAPTCHA


LATEST POSTS

Ethereum Value Setting For a Large Transfer – Breakout Or Downturn?

Este artículo también está disponible en español. Ethereum has confronted challenges in regaining its bullish momentum, leaving the altcoin buying and selling at a pivotal stage....

Bitcoin $100K push: What liquidation zones reveal about BTC’s future

Bitcoin’s vacation rally brings it near $100K, fueling hypothesis and heightened volatility. Leverage and market sentiment is important as BTC navigates liquidation zones and key value...

The sunshine of TCM inheritance, the physician’s benevolence creates miracles – Blockchain Information Website

When fashionable drugs occupies the forefront of the medical area with its fast improvement, there may be an historic and profound medical knowledge, which is...

Galectin Therapeutics' chief medical officer sells $12,044 in shares By Investing.com

Jamil Khurram, the Chief Medical (TASE:) Officer of Galectin Therapeutics Inc. (NASDAQ:), lately offered 13,654 shares of the corporate's widespread inventory....

Most Popular